IPO
-
-
-
-
-
-
-
BridgeBio Oncology Therapeutics to go Public via Merger with Helix Acquisition Cp II (HLXB)
-
-
-
-
-
-
-
BridgeBio Pharma, Inc. Secures Up to $750 Million in Non-Dilutive Debt Financing
-
-
-
-
-
-
-
BridgeBio Pharma Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Portfolio Progress
-
-
-
-
-
-
-
BridgeBio Pharma Announces Pricing of Its Initial Public Offering
122,340 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

